Skip to main navigation Skip to search Skip to main content

Use of estradiol–progestin therapy associates with increased risk for uterine sarcomas

  • Susanna Jaakkola
  • , Heli K Lyytinen
  • , Eero Pukkala
  • , Olavi Ylikorkala

    Research output: Contribution to journalArticleScientificpeer-review

    20 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)260-263
    JournalGynecologic Oncology
    Volume122
    Issue number2
    DOIs
    Publication statusPublished - 2011
    Publication typeA1 Journal article-refereed

    Keywords

    • Uterine sarcoma
    • estrogen
    • hormone therapy
    • leiomyosarcoma
    • progestin
    • stromal sarcoma

    Cite this